InsidersTradesSigma
Follow the ST中珠 share price and the full insider trade history of the company, a listed issuer based in China. Shares are quoted on the CN market, under the authority of SSE / SZSE (CSRC). Operating in the Health Care sector, ST中珠 has published 6 insider filings. Market capitalisation: €4.6bn. The latest transaction was reported on 7 June 2021 (Purchase). Among the most active insiders: 叶继革. All data is free.
6
Insider Decl.
n/a
Thresholds
€106,233
6 ops.
Buy Volume
n/a
n/a
Sell Volume
14Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 24,830 of 28,717 companies
25.4
score / 100
Value34
Quality17
FCF yld0.5%
Earn yld-2.5%
EV/EBITDA·
ROE-7.1%
Gross mgn18%
Net mgn-20%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 7 June 2021
Declarations6 total
6 of 6 declarations
About ST中珠
ST中珠 is a company listed on the XSHG market, specializing in the healthcare and pharmaceutical sector. It focuses on the development and distribution of pharmaceutical products.